Работы, на которые ссылается эта работа

Работ: 121

Работа: Aptamer-based approaches in leukemia: a paradigm shift in targeted therapy

Unveiling the potential of CLL-1: a promising target for AML therapy
Hamed Soleimani Samarkhazan, Sara Zehtabcheh, Hamideh Rahmani Seraji +4
Обзорная статья2025Цитирований: 6
ABI
Macrophages in graft-versus-host disease (GVHD): dual roles as therapeutic tools and targets
Atieh Raoufi, Hamed Soleimani Samarkhazan, Sina Nouri +5
Обзорная статья2025Цитирований: 5
ABI
Aqueous and ethanolic extracts of Moringa oleifera leaves induce selective cytotoxicity in Raji and Jurkat cell lines by activating the P21 pathway independent of P53
Leila Rajabi, Mostafa Ebrahimdoost, Seyed Amin Mohammadi +3
Статья2025Цитирований: 5
ABI
Role of Precision Medicine and Personalized Medicine in the Treatment of Diseases
Mehrdad Farrokhi, Fatemeh Taheri, Parisa Jafari Khouzani +25
Книга2023Цитирований: 4
ABI
Platelet-derived extracellular vesicles: emerging players in hemostasis and thrombosis
Aziz Kubaev, Fadhil Faez Sead, Mohammad Pirouzbakht +6
Обзорная статьяExtracellular vesicles in diseaseJournal of Liposome Research2025Цитирований: 4
ABI
Aptamers used for biosensors and targeted therapy
Yi Ning, Jue Hu, Fangguo Lu
Обзорная статья2020Цитирований: 3
ABI
Molecular targeted therapy: Treating cancer with specificity
Yeuan Ting Lee, Yi Jer Tan, Chern Ein Oon
Обзорная статья2018Цитирований: 3
ABI
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application
Tatsuo Adachi, Yoshikazu Nakamura
Обзорная статья2019Цитирований: 3
ABI
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
Julia Hoellenriegel, Dirk Zboralski, Christian Maasch +5
Статья2013Цитирований: 2
ABI
Identification and Characterization of an Agonistic Aptamer Against the T Cell Costimulatory Receptor, OX40
Elizabeth D. Pratico, Bruce A. Sullenger, Smita K. Nair
Статья2012Цитирований: 2
ABI
Aptamers and aptamer targeted delivery
Amy Yan, Matthew Levy
Обзорная статья2009Цитирований: 2
ABI
Aptamers: current challenges and future prospects
Guido Tomás Rozenblum, Vanina Gisela Lopez, Alfredo Daniel Vitullo +1
Обзорная статья2015Цитирований: 2
ABI
Aptamers: A promising chemical antibody for cancer therapy
Gang Zhou, George D. Wilson, Lionel Hebbard +4
Обзорная статья2016Цитирований: 2
ABI
Aptamers as targeted therapeutics: current potential and challenges
Jiehua Zhou, John J. Rossi
Обзорная статья2016Цитирований: 2
ABI
Recent Progress in Aptamer Discoveries and Modifications for Therapeutic Applications
Shuaijian Ni, Zhenjian Zhuo, Yufei Pan +12
Обзорная статья2020Цитирований: 2
ABI
Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
Prabir Kumar Kulabhusan, Babar Hussain, Meral Yüce
Обзорная статья2020Цитирований: 2
ABI
Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy
Jing Han, Liang Gao, Jinsheng Wang +1
Обзорная статья2020Цитирований: 2
ABI
Development and characterization of a DNA aptamer for MLL-AF9 expressing acute myeloid leukemia cells using whole cell-SELEX
Kaylin G. Earnest, Erin M. McConnell, Eman M. Hassan +8
Статья2021Цитирований: 2
ABI
Progress in construction of mouse models to investigate the pathogenesis and immune therapy of human hematological malignancy
Yue Lang, Yanan Lyu, Yehui Tan +1
Обзорная статья2023Цитирований: 2
ABI
Von Willebrand disease (VWD) and pregnancy: a comprehensive overview
Hamed Soleimani Samarkhazan, Mohammad Navid Khaksari, Ali Rahmati +3
Обзорная статья2025Цитирований: 2
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI
Без названия
ДругоеЦитирований: 1
ABI